SLN logo

Silence Therapeutics plc (SLN)

Profile

Full Name

Silence Therapeutics plc

Ticker Symbol

NASDAQ: SLN

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United Kingdom

IPO

September 8, 2020

Indexes

Not included

Website

http://www.silence-therapeutics.com

Employees

116

Key Details

Price

$5.52(-2.99%)

Market cap

$260.71M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$43.26M(+36.71% YoY)

Annual EPS

-$0.99(+32.65% YoY)

PE ratio

-

Next earnings date

Aug 15, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $5.52
    SLN price is $5.52

    30-Day Relative Volume

    0.22
    SLN 30-day relative volume is 0.22

    Price Performance

    Price Most recent change

    -2.99%
    SLN price was down -2.99% on Jul 3, 2025

    Price YTD change

    -19.77%
    SLN price is down -19.77% since January 1st

    Price 1-year change

    -69.28%
    SLN price is down -69.28% year-on-year

    Price 3-year change

    -54%
    SLN price is down -54% over the past 3 years

    Price Range

    Price All-time high

    $35.00
    SLN price is currently -84.23% below its historical high of $35.00

    Price 3-year low

    $1.97
    SLN price is currently +180.20% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $260.71M
    SLN market capitalization is $260.71 million

    Market cap 3-year change

    -27.43%
    SLN market capitalization is down -27.43% over the past 3 years

    Market cap All-time high

    $1.25B
    SLN market capitalization is currently -79.13% below its historical high of $1.25 billion

    Market cap sector rank

    56.85%
    SLN market capitalization is higher than 56.85% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.92%
    SLN shares outstanding is up +0.92% year-on-year

    Shares Outstanding 3-Year Change

    +57.76%
    SLN shares outstanding is up +57.76% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.66
    SLN beta is 0.66

    200-day SMA

    $8.01
    SLN price is currently -31.05% below its 200-day simple moving average

    50-day SMA

    $4.86
    SLN price is currently +13.65% above its 50-day simple moving average

    RSI

    51.95
    SLN 14-day relative strength index is 51.95

    Volume

    0.22
    SLN 30-day relative volume is 0.22

    ATR

    $0.44
    SLN average true range is $0.44

    10-day Historical Volatility

    63.28%
    SLN 10-day historical volatility is 63.28%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $43.26M
    SLN annual revenue is $43.26 million

    Revenue Analysts estimate

    $16.93M
    SLN annual revenue is currently +155.56% higher than the consensus analysts' forecast

    Revenue 1-year change

    +36.71%
    SLN annual revenue is up +36.71% year-on-year

    Revenue Sector rank

    44.96%
    SLN annual revenue is higher than 44.96% of companies in Healthcare sector

    EPS

    EPS

    -$0.99
    SLN annual earnings per share is -$0.99

    EPS Analysts estimate

    -$0.84
    SLN annual earnings per share is currently +18.21% higher than the consensus analysts' forecast

    EPS 1-year change

    +32.65%
    SLN annual earnings per share is up +32.65% year-on-year

    EPS Sector rank

    56.47%
    SLN annual earnings per share is higher than 56.47% of companies in Healthcare sector

    Profit

    Gross profit

    $31.45M
    SLN annual gross profit is $31.45 million

    Gross margin

    72.70%
    SLN annual gross profit margin is 72.70%

    Operating profit

    -$63.32M
    SLN annual operating income is -$63.32 million

    Operating margin

    -114.62%
    SLN annual operating profit margin is -114.62%

    Net income

    -$45.31M
    SLN annual net profit is -$45.31 million

    Net margin

    -104.74%
    SLN annual net profit margin is -104.74%

    Expenses

    Total expenses

    $106.58M
    SLN annual total expenses is $106.58 million

    Operating expenses

    $94.77M
    SLN annual total operating expenses is $94.77 million

    Cost of goods sold

    $11.81M
    SLN annual cost of goods sold is $11.81 million

    Selling, general & administrative expenses

    $26.88M
    SLN annual SGA is $26.88 million

    Depreciation and amortization

    $593.00K
    SLN annual depreciation & amortization is $593.00 thousand

    Interest expense

    -
    SLN annual interest expense value is unknown

    Income tax

    $845.00K
    SLN annual income tax is $845.00 thousand

    EBIT & EBITDA

    EBIT

    -$63.32M
    SLN annual earnings before interest & taxes is -$63.32 million

    EBITDA

    -$63.32M
    SLN annual EBITDA is -$63.32 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $202.63M
    SLN annual total assets is $202.63 million

    Non current assets

    $15.27M
    SLN annual long term assets is $15.27 million

    Current assets

    $187.37M
    SLN annual total current assets is $187.37 million

    Cash and cash equivalents

    $121.33M
    SLN annual cash & cash equivalents is $121.33 million

    Accounts receivable

    $972.00K
    SLN annual accounts receivable is $972.00 thousand

    Inventory

    -
    SLN annual inventory value is unknown

    Liabilities

    Total liabilities

    $68.61M
    SLN annual total liabilities is $68.61 million

    Long term liabilities

    $51.79M
    SLN annual total long term liabilities is $51.79 million

    Current liabilities

    $16.82M
    SLN annual total current liabilities is $16.82 million

    Accounts payable

    $16.40M
    SLN annual accounts payable is $16.40 million

    Debt

    Total debt

    $117.00K
    SLN annual total debt is $117.00 thousand

    Total debt 1-year change

    -66.18%
    SLN annual total debt is down -66.18% year-on-year

    Long term debt

    $0.00
    SLN annual long term debt is $0.00

    Short term debt

    $117.00K
    SLN annual short term debt is $117.00 thousand

    Equity & Capital

    Shareholders equity

    $134.02M
    SLN annual stockholders equity is $134.02 million

    Book value

    $134.02M
    SLN annual book value is $134.02 million

    Retained earnings

    -$474.04M
    SLN annual retained earnings is -$474.04 million

    Working capital

    $170.54M
    SLN annual working capital is $170.54 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$67.64M
    SLN annual cash flow from operations is -$67.64 million

    Cash from operations 1-year change

    -36.75%
    SLN annual cash flow from operations is down -36.75% year-on-year

    Cash from investing

    -$21.97M
    SLN annual cash flow from investing activities is -$21.97 million

    Cash from investing 1-year change

    -213.85%
    SLN annual cash flow from investing activities is down -213.85% year-on-year

    Cash from financing

    $142.09M
    SLN annual cash flow from financing activities is $142.09 million

    Cash from financing 1-year change

    +344.9%
    SLN annual cash flow from financing activities is up +344.9% year-on-year

    CAPEX

    CAPEX

    $211.00K
    SLN annual capital expenditures is $211.00 thousand

    CAPEX 1-year change

    +276.79%
    SLN annual capital expenditures is up +276.79% year-on-year

    Free Cash Flow

    Free cash flow

    -$67.85M
    SLN annual free cash flow is -$67.85 million

    Free cash flow 1-year change

    -37.02%
    SLN annual free cash flow is down -37.02% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    72.70%
    SLN annual gross profit margin is 72.70%

    Operating margin

    -114.62%
    SLN annual operating profit margin is -114.62%

    Net margin

    -104.74%
    SLN annual net profit margin is -104.74%

    ROA & ROE

    ROA

    -28.14%
    SLN annual return on assets is -28.14%

    ROE

    -58.08%
    SLN annual return on equity is -58.08%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    SLN price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    SLN price to earnings ratio is unknown

    PB Ratio

    PB ratio

    -2.31
    SLN price to book ratio is -2.31

    PB ratio Sector rank

    7.55%
    SLN price to book ratio is higher than 7.55% of companies in Healthcare sector

    PS Ratio

    PS ratio

    9.74
    SLN price to sales ratio is 9.74

    PS ratio Sector rank

    77.59%
    SLN price to sales ratio is higher than 77.59% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $195.89M
    SLN enterprise value is $195.89 million

    Enterprise value Sector rank

    54.51%
    SLN enterprise value is higher than 54.51% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -2.85
    SLN EV/EBITDA is -2.85

    EV/EBITDA Sector rank

    32.84%
    SLN EV/EBITDA is higher than 32.84% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    11.14
    SLN annual current ratio is 11.14

    Quick ratio

    -
    SLN annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.00
    SLN annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    SLN annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    SLN piotroski f-score value is unknown

    Altman Z-Score

    -0.80
    SLN altman z-score is -0.80

    Analyst ratings

    Recent major analysts updates

    Jun 13, 25 HC Wainwright & Co.
    Buy
    Jun 13, 25 Chardan Capital
    Buy
    May 9, 25 Morgan Stanley
    Overweight
    May 9, 25 Goldman Sachs
    Sell
    May 9, 25 Chardan Capital
    Buy
    Mar 7, 25 HC Wainwright & Co.
    Buy
    Mar 5, 25 Morgan Stanley
    Overweight
    Mar 4, 25 Goldman Sachs
    Sell
    Mar 4, 25 BMO Capital
    Outperform
    Feb 11, 25 Goldman Sachs
    Sell

    Institutional Ownership

    Screeners with SLN included

    Growing Shares Outstanding
    UK stocks
    Stocks below SMA 200
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for Silence Therapeutics plc?
    • Does Silence Therapeutics plc pay dividends?
    • What sector is Silence Therapeutics plc in?
    • What industry is Silence Therapeutics plc in?
    • What country is Silence Therapeutics plc based in?
    • When did Silence Therapeutics plc go public?
    • Is Silence Therapeutics plc in the S&P 500?
    • Is Silence Therapeutics plc in the NASDAQ 100?
    • Is Silence Therapeutics plc in the Dow Jones?
    • When was Silence Therapeutics plc's last earnings report?
    • When does Silence Therapeutics plc report earnings?

    What is the ticker symbol for Silence Therapeutics plc?

    The ticker symbol for Silence Therapeutics plc is NASDAQ:SLN

    Does Silence Therapeutics plc pay dividends?

    No, Silence Therapeutics plc does not pay dividends

    What sector is Silence Therapeutics plc in?

    Silence Therapeutics plc is in the Healthcare sector

    What industry is Silence Therapeutics plc in?

    Silence Therapeutics plc is in the Biotechnology industry

    What country is Silence Therapeutics plc based in?

    Silence Therapeutics plc is headquartered in United Kingdom

    When did Silence Therapeutics plc go public?

    Silence Therapeutics plc's initial public offering (IPO) was on September 8, 2020

    Is Silence Therapeutics plc in the S&P 500?

    No, Silence Therapeutics plc is not included in the S&P 500 index

    Is Silence Therapeutics plc in the NASDAQ 100?

    No, Silence Therapeutics plc is not included in the NASDAQ 100 index

    Is Silence Therapeutics plc in the Dow Jones?

    No, Silence Therapeutics plc is not included in the Dow Jones index

    When was Silence Therapeutics plc's last earnings report?

    Silence Therapeutics plc's most recent earnings report was on May 8, 2025

    When does Silence Therapeutics plc report earnings?

    The next expected earnings date for Silence Therapeutics plc is August 15, 2025
    On this page